PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDiethylpropion
Diethylpropion
Diethylpropion (diethylpropion) is a small molecule pharmaceutical. Diethylpropion was first approved as Tepanil on 1982-01-01. It is used to treat obesity in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
nutritional and metabolic diseasesD009750
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Diethylpropion (discontinued: Diethylpropion, Tenuate, Tenuate dospan, Tepanil, Tepanil ten-tab)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Diethylpropion hydrochloride
Tradename
Company
Number
Date
Products
TEPANIL3MN-011673 DISCN1982-01-01
1 products
TEPANIL TEN-TAB3MN-017956 DISCN1982-01-01
1 products
TENUATENostrum LaboratoriesN-011722 DISCN1982-01-01
1 products, RLD
TENUATE DOSPANNostrum LaboratoriesN-012546 DISCN1982-01-01
1 products, RLD
TENUATESanofiN-017668 DISCN1982-01-01
1 products
TENUATESanofiN-017669 DISCN1982-01-01
1 products
Hide discontinued
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
obesityEFO_0001073D009765E66.9
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
A08: Antiobesity preparations, excl. diet products
A08A: Antiobesity preparations, excl. diet products
A08AA: Centrally acting antiobesity products
A08AA03: Amfepramone
HCPCS
No data
Clinical
Clinical Trials
4 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.9123
Indications Phases 3
No data
Indications Phases 2
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
OverweightD050177E66.311
PregnancyD011247EFO_0002950Z33.111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDiethylpropion
INNamfepramone
Description
Diethylpropion is an aromatic ketone that is propiophenone in which one of the hydrogens alpha- to the carbonyl is substituted by a diethylamino group. A central stimulant and indirect-acting sympathomimetic, it is an appetite depressant and is used as the hydrochloride as an anoretic in the short term management of obesity. It has a role as an appetite depressant. It is a tertiary amine and an aromatic ketone. It is functionally related to a propiophenone.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCN(CC)C(C)C(=O)c1ccccc1
Identifiers
PDB
CAS-ID90-84-6
RxCUI
ChEMBL IDCHEMBL1194666
ChEBI ID4530
PubChem CID7029
DrugBankDB00937
UNII IDQ94YYU22B8 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Diethylpropion
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 690 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
49 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use